Inflammatory bowel disease is associated with increased complications after total knee arthroplasty.

[1]  J. Parvizi,et al.  Inflammatory Bowel Diseases Increase the Risk of Periprosthetic Joint Infection , 2021, The Journal of bone and joint surgery. American volume.

[2]  D. Manuel,et al.  Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease , 2020, Canadian Medical Association Journal.

[3]  T. H. Nguyen,et al.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[4]  S. Puloski,et al.  Association between Allogeneic Blood Transfusion and Wound Infection after Total Hip or Knee Arthroplasty: A Retrospective Case-Control Study , 2019, Journal of bone and joint infection.

[5]  Dustin L. Stwalley,et al.  Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty , 2018, Journal of Crohn's & colitis.

[6]  J. Halfvarson,et al.  Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study , 2018, Alimentary pharmacology & therapeutics.

[7]  G. Solina,et al.  Clinical course of severe colitis: a comparison between Crohn’s Disease and ulcerative colitis. , 2018, Journal of Biological Regulators and Homeostatic Agents.

[8]  Michael A Mont,et al.  Risk Factors and Costs Associated With Clostridium difficile Colitis in Patients With Prosthetic Joint Infection Undergoing Revision Total Hip Arthroplasty. , 2018, The Journal of arthroplasty.

[9]  L. Mandl,et al.  US Trends in Rates of Arthroplasty for Inflammatory Arthritis Including Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritis , 2014, Arthritis & rheumatology.

[10]  Michael A Mont,et al.  Higher revision and complication rates following total hip arthroplasty in patients with inflammatory bowel disease. , 2014, The Journal of arthroplasty.

[11]  T. Gheita,et al.  Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results , 2014, Clinical Rheumatology.

[12]  J. Parvizi,et al.  Clostridium difficile Colitis in Patients Undergoing Lower-extremity Arthroplasty: Rare Infection With Major Impact , 2013, Clinical orthopaedics and related research.

[13]  P. Bozko,et al.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? , 2013, Therapeutic advances in gastroenterology.

[14]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[15]  Dawn B. Beaulieu,et al.  Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  L. Melton,et al.  Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004 , 2006, Gut.

[17]  E. P. Dellinger,et al.  Infectious and immunologic consequences of blood transfusion , 2004, Critical care.

[18]  Judy H. Cho,et al.  Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease , 2002, Clinical Microbiology Reviews.

[19]  T. Wheatley,et al.  Effect of blood transfusion on postoperative immunocompetence. , 1997, British journal of anaesthesia.

[20]  M. R. Mickey,et al.  Effect of blood transfusions on subsequent kidney transplants. , 1973, Transplantation proceedings.